Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Patrick Plitt
Introduction
Patrick Plitt is an accomplished inventor based in Bad Homburg, Germany. He has made significant contributions to the field of medical treatments, particularly in addressing issues related to implanted tissue fillers. His innovative approach has led to the development of a unique method that enhances patient outcomes.
Latest Patents
Patrick Plitt holds a patent for "Methods and compositions for treating undesired implanted tissue filler." This patent describes a method for treating undesired implanted calcium phosphate tissue filler by administering an effective amount of a pharmaceutically acceptable hyperosmotic composition. The hyperosmotic composition may be a hyperosmotic solution, particularly a hyperosmotic aqueous solution. This composition is administered to an area containing the undesired calcium phosphate tissue filler. The administration of the hyperosmotic composition can reduce, dilute, or redistribute an undesired amount or accumulation of implanted calcium phosphate tissue filler. The methods outlined in this patent can ameliorate undesired filler that is implanted in an unintended location, that migrates to an undesired location, or that results in an undesired visual result. Additionally, it addresses issues related to compression of surrounding tissue, pain, infection, and inflammation.
Career Highlights
Throughout his career, Patrick Plitt has worked with notable companies, including Merz North America, Inc. and Ramot at Tel-Aviv University Ltd. His experience in these organizations has contributed to his expertise in the field of medical innovations.
Collaborations
Patrick has collaborated with esteemed colleagues such as Wojciech Danysz and Peter Kreymerman. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Patrick Plitt's innovative methods for treating undesired implanted tissue fillers demonstrate his commitment to improving medical treatments. His contributions have the potential to enhance patient care and address significant challenges in the field.